BSEInsider Trading / SAST27 Sept 2026 · 27 Sept 2026, 09:36 pm
We hereby inform you that the Trading Window for dealing in the securities of the company shall remain closed for all designated persons and their Immediate Relatives with effected from October 01, 2026.
Asarfi Hospital Ltd · 543943
✦ AI Summaryinsider
Asarfi Hospital Ltd has announced the closure of its trading window for all designated persons and their immediate relatives, effective from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Asarfi Hospital Ltd - 543943 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
780f1ba2-5406-446f-b102-4cf2a3b14a9f.pdf
View document text
असफ(cid:334) हॉ(cid:729)ीटल
सबके िलए (cid:738)ा(cid:726)
Ref. No.: AHL/AO/2026/1403 Date: 26.09.2026
The BSE Limited
Listing Department
25th Floor, Phiroze Jeejeebhoy Tower
Dalal Street, Mumbai – 400001
Subject: Intimation regarding Closure of Trading Window under SEBI (Prohibition of Insider
Trading) Regulations, 2015
Ref.: Scrip Code: 543943
Dear Sir/Madam,
Pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider
Trading) Regulations, 2015, as amended from time to time, and the Company's Code of Conduct for
Prevention of Insider Trading, we hereby inform you that the Trading Window for dealing in the
securities of the Company shall remain closed for all Designated Persons and their Immediate
Relatives with effect from October 01, 2026.
The Trading Window shall remain closed until 48 hours after the declaration of the Unaudited
Financial Results of the Company for the quarter & half year ended September 30, 2026.
The date of the Board Meeting for consideration and approval of the Unaudited Financial Results for
the quarter & half year ended September 30, 2026, shall be intimated separately in due course.
You are requested to kindly take the above information on record.
Thanking you,
Yours faithfully,
For Asarfi Hospital Limited
CS Sudipa Singh
Company Secretary & Compliance Officer
Asarfi Hospital Limited
Baramuri, P.O.: B Polytechnic, Dhanbad 828 130 || CIN: L85110JH2005PLC011673
Branch Office: Khatal Road, Dhaiya, ISM, Dhanbad 826004 || www.asarfihospital.com
Phone: 7808368888, 9234302735 || Email: info@asarfihospital.com